Podkarpacki Osrodek Pulmonologii i Alergologii Sp. z o.o.
- Address
- ul. Wladyslawa Warnenczyka 111, 35-612 Rzeszów, Poland
Podkarpacki Osrodek Pulmonologii i Alergologii Sp. z o.o.
Podkarpacki Osrodek Pulmonologii i Alergologii is a specialized pulmonology and allergology research center dedicated to advancing treatments for respiratory conditions and allergic diseases. The center demonstrates particular expertise in pediatric respiratory medicine, conducting clinical investigations focused on severe asthma presentations in younger patient populations.
- Severe eosinophilic asthma in pediatric and adolescent patients
- Biologic therapies for uncontrolled asthma management
- Eosinophil-mediated inflammatory airway diseases
The center's research portfolio emphasizes innovative approaches to managing severe eosinophilic asthma, a condition characterized by elevated levels of eosinophils—white blood cells that contribute to airway inflammation and compromised lung function. Their clinical trials evaluate targeted biologic therapies aimed at reducing asthma exacerbations and improving disease control in pediatric patients who remain uncontrolled despite standard treatments. This focus on vulnerable patient populations demonstrates the center's commitment to addressing unmet medical needs in respiratory medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Podkarpacki Osrodek Pulmonologii i Alergologii Sp. z o.o.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicentre, Randomised, Double-blind, Parallel Group, Placebocontrolled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eosinophilic Asthma (DOMINICA) | AstraZeneca AB | Phase III | Not Recruiting | Jun 2023 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ads-015 | 1 | Unknown | 2023-06-21 | 2023-06-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.